Jetema Co Ltd
KOSDAQ:216080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jetema Co Ltd
Stock-Based Compensation
Jetema Co Ltd
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jetema Co Ltd
KOSDAQ:216080
|
Stock-Based Compensation
₩136.4m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Stock-Based Compensation
₩549m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Stock-Based Compensation
₩3.6B
|
CAGR 3-Years
291%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jetema Co Ltd
Glance View
Jetema Co., Ltd. is engaged in the manufacturing and distributing of aesthetic products, including dermal filler, a thread, a botulinum toxin and other medical devices. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2019-11-14. CO,.LTD is a Korea-based company principally engaged in the development and manufacturing of hyaluronic acid fillers used for facial beauty and other medical devices. The firm manufactures and sells medical devices for improvement of wrinkle, contour and volume. In addition, the Company also engages in the manufacturing and sale of laser equipment used for treatment of leukoplakia, psoriasis and alopecia areata, lifting medical device epiticons, cosmetic mask packs, pharmaceutical excaine creams as well as others.
See Also
What is Jetema Co Ltd's Stock-Based Compensation?
Stock-Based Compensation
136.4m
KRW
Based on the financial report for Dec 31, 2024, Jetema Co Ltd's Stock-Based Compensation amounts to 136.4m KRW.
What is Jetema Co Ltd's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-27%
Over the last year, the Stock-Based Compensation growth was -54%. The average annual Stock-Based Compensation growth rates for Jetema Co Ltd have been -47% over the past three years , -27% over the past five years .
